Surgery Partners, Inc. (NASDAQ:SGRY) Receives $22.18 Average PT from Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has earned a consensus recommendation of “Moderate Buy” from the twelve research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $22.1818.

A number of research analysts recently issued reports on the stock. UBS Group restated a “buy” rating on shares of Surgery Partners in a research report on Wednesday, March 11th. Zacks Research upgraded shares of Surgery Partners from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a research report on Tuesday, May 26th. US Capital Advisors set a $21.00 price objective on shares of Surgery Partners in a research report on Wednesday, March 11th. Finally, Benchmark reiterated a “buy” rating on shares of Surgery Partners in a research report on Tuesday, March 3rd.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Jones Financial Companies Lllp grew its stake in shares of Surgery Partners by 313.1% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock valued at $27,000 after buying an additional 930 shares during the period. PNC Financial Services Group Inc. boosted its position in Surgery Partners by 239.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after buying an additional 2,051 shares during the period. Fifth Third Bancorp boosted its position in Surgery Partners by 5,324.0% in the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after buying an additional 3,993 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in Surgery Partners by 45,640.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after buying an additional 2,282 shares during the period. Finally, Aquatic Capital Management LLC purchased a new position in Surgery Partners in the 3rd quarter valued at approximately $121,000.

Surgery Partners Stock Performance

Surgery Partners stock opened at $14.53 on Wednesday. The company has a 50 day moving average price of $14.05 and a 200-day moving average price of $14.40. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.69 and a current ratio of 1.86. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $24.10. The company has a market capitalization of $1.90 billion, a PE ratio of -24.22, a P/E/G ratio of 4.35 and a beta of 1.96.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.12. The company had revenue of $810.90 million for the quarter, compared to analyst estimates of $797.69 million. Surgery Partners had a negative net margin of 2.28% and a positive return on equity of 1.04%. Surgery Partners’s revenue was up 4.5% compared to the same quarter last year. During the same period last year, the company posted $0.04 earnings per share. As a group, equities analysts forecast that Surgery Partners will post 0.25 earnings per share for the current year.

Surgery Partners declared that its Board of Directors has authorized a share repurchase program on Thursday, February 26th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the company to buy up to 9.7% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.